Quetiapine and Wolff-Parkinson-White Syndrome

Authors

Michael Chen, Lehigh Valley Health Network
Hassaan Gomaa, Penn State Hershey Medical Center
Alonso Cortez-Resendiz, Penn State Hershey Medical Center
Christopher Martin, Thomas Jefferson UniversityFollow
Andrew Francis, Penn State Hershey Medical Center
Alfredo Bellon, Penn State Hershey Medical Center, Penn State College of Medicine

Document Type

Article

Publication Date

1-1-2020

Comments

This is the final published version of the article from Case Reports in Psychology, 2020 Dec 11;2020:6633385.

The article can also be accessed at the journal's website: https://doi.org/10.1155/2020/6633385

Copyright. The Authors.

Abstract

Quetiapine is occasionally associated with cardiovascular adverse effects such as QTc prolongation. QTc prolongation is a side effect that requires monitoring in order to avoid more serious cardiac complications. One particular understudied area is the potential for antipsychotics to elicit electroconduction abnormalities in patients with Wolff-Parkinson-White (WPW) Syndrome. In the present report, we describe a case of quetiapine overdose in a patient with WPW.

Recommended Citation

Chen, Michael; Gomaa, Hassaan; Cortez-Resendiz, Alonso; Martin, Christopher; Francis, Andrew; and Bellon, Alfredo, "Quetiapine and Wolff-Parkinson-White Syndrome" (2020). Department of Psychiatry and Human Behavior Faculty Papers. Paper 61.
https://jdc.jefferson.edu/phbfp/61

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

33381342

Language

English